NDC 0093-5234 – Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

Efavirenz 600 mg/1; Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC0093-5234

Product details

Brand name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA091215
Marketed since
October 1, 2020
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Efavirenz, emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
0093-5234-5630 TABLET, FILM COATED in 1 BOTTLE (0093-5234-56)Oct 1, 2020

Other Efavirenz, emtricitabine and tenofovir disoproxil fumarate products